Phase II study of weekly Gemcitabine in patients with metastatic breast cancer relapsing or failing both an antracycline and a taxane

Research output: Contribution to journal › Article › Academic › peer-review

82 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	83-87
Number of pages	5
Journal	Breast Cancer Research and Treatment
Volume	66
DOIs	https://doi.org/10.1023/A:1010679127390
Publication status	Published - 2001

Research programs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{96f62b30f6b541128b9cc2292b2a4b68,

title = "Phase II study of weekly Gemcitabine in patients with metastatic breast cancer relapsing or failing both an antracycline and a taxane",

author = "CH Smorenburg and Marijke Bontenbal and Caroline Seynaeve and Lia Zuylen and G Heus and Jaap Verweij and \{de Wit\}, Ronald",

year = "2001",

doi = "10.1023/A:1010679127390",

language = "Undefined/Unknown",

volume = "66",

pages = "83--87",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

}

TY - JOUR

T1 - Phase II study of weekly Gemcitabine in patients with metastatic breast cancer relapsing or failing both an antracycline and a taxane

AU - Smorenburg, CH

AU - Bontenbal, Marijke

AU - Seynaeve, Caroline

AU - Zuylen, Lia

AU - Heus, G

AU - Verweij, Jaap

AU - de Wit, Ronald

PY - 2001

Y1 - 2001

U2 - 10.1023/A:1010679127390

DO - 10.1023/A:1010679127390

M3 - Article

SN - 0167-6806

VL - 66

SP - 83

EP - 87

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

ER -